Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +12.9% | -20.0% | 1 / 3 | +4.9% | +2.56 pp | +0.94 pp | +18.7% | 0.16 | 9.68 | 306 | +4,9% | 40,4 | +12,9% | 9.68 | 10.79 | −10,3% |
| Pts | 0 | 0 | 4 | 0 | 8 | 8 | 8 | 12 | 8 | |||||||
Valuation annotation:Price: 32.000 (close price on 2026-10-19)EPS (TTM): 3.307
Financial charts
1.Revenue & growth
VND bn307Q2/26
1.Revenue & growth
VND bn307Q2/26
2.Profit & growth
VND bn41,5Q2/26
3.Profit mix (Penman)
VND bn201Q2/26
4.Margins & cost structure
%18.9%Q2/26
5.Returns & cash cycle
% · days27.8%Q2/26
6.Earnings quality & cash
VND bn228Q2/26
7.Asset structure
VND bn1.346Q2/26
8.Funding & debt health
VND bn · times1.346Q2/26
9.Revenue backlog
VND bn19,3Q2/26
10.Valuation
times · %9,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %865Q2/26
Adjusted EPS growth, latest quarter
16.0%
Average adjusted EPS growth, 3 quarters
-19.0%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26